The clinical significance of the DNMT1 and DNMT3b high expression was evaluated in ERα-positive breast cancer patients by Kaplan-Meier Plotter analysis (http://kmplot.com/breast/). The gene discussed is DNMT3B; the disease is breast carcinoma.